Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

Pan-betacoronavirus neutralizing antibodies may hold the key to developing broadly protective vaccines against novel pandemic coronaviruses and to more effectively respond to SARS-CoV-2 variants. The emergence of Omicron and subvariants of SARS-CoV-2 illustrates the limitations of solely targeting t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Panpan, Song, Ge, Liu, Hejun, Yuan, Meng, He, Wan-ting, Beutler, Nathan, Zhu, Xueyong, Tse, Longping V., Martinez, David R., Schäfer, Alexandra, Anzanello, Fabio, Yong, Peter, Peng, Linghang, Dueker, Katharina, Musharrafieh, Rami, Callaghan, Sean, Capozzola, Tazio, Limbo, Oliver, Parren, Mara, Garcia, Elijah, Rawlings, Stephen A., Smith, Davey M., Nemazee, David, Jardine, Joseph G., Safonova, Yana, Briney, Bryan, Rogers, Thomas F., Wilson, Ian A., Baric, Ralph S., Gralinski, Lisa E., Burton, Dennis R., Andrabi, Raiees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933850/
https://www.ncbi.nlm.nih.gov/pubmed/36889306
http://dx.doi.org/10.1016/j.immuni.2023.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933850/
https://www.ncbi.nlm.nih.gov/pubmed/36889306
http://dx.doi.org/10.1016/j.immuni.2023.02.005

Ejemplares similares